FROM NUCLEOSIDES TO MONOSACCHARIDES TO CHIRALS IN PRATTELN
Founded in 2000, we are a tailor-made research and development organization with an expanded portfolio that extends from the synthesis route to process chemistry.
SynphaBase AGis a leading company that offers competencies in medicinal chemistry as well as enabling process research and development.
We work with competent partners who enable us to give you the opportunity to produce commercial batches under the quality management GMP using processes developed and tested by SynphaBase .
In the past 16 years we have successfully completed over 2000 projects from milligrams to multi-kilograms (not GMP). The basis of our success is our consistent ability to develop and improve sophisticated production processes that enable us to deliver quality assured products. Punctual delivery, clear communication and a transparent attitude help us to manage complex projects and to meet the requirements of our customers.
DR. ARTHUR BODENMÜLLER EXECUTIVE DIRECTOR
Arthur Bodenmüller is a co-founder of SynphaBase AG, a specialist research company that focuses on the synthesis of complex organic compounds. The company was founded in November 2000 at the University of Applied Sciences in Muttenz / Basel. Arthur has been the company's chief executive officer (CEO) ever since. In 2013 he became president and owner of SynphaBase.
Arthur received his doctorate in chemistry at the University of Konstanz in 1993 (with Prof. Dr. RR Schmidt) and then joined the group of Prof. P. Sinaÿ at the École Normale Supérieur in Paris. The subject of his scientific work was in the field of carbohydrate chemistry. In 1994 he started his industrial career as a laboratory chemist at Neosystem in Strasbourg, now a subsidiary of PolyPeptide, and focused on the synthesis of unnatural acids and small peptides. He joined Senn Chemicals in Dielsdorf (CH) in 1997, where he was responsible for research and development before moving to the marketing and sales department. Arthur has been a member of the FHNW / Muttenz advisory board since 2010.
DR. ANDREAS GREB PROJECT LEADER
Andreas studied chemistry at the Rheinische Friedrich-Wilhelms-Universität Bonn and the University of Southern Denmark, Odense. After completing his diploma in chemistry, he did his doctorate in organic chemistry at RWTH Aachen under the direction of Professor Dieter Enders. He then worked as a research chemist at Syncom. In 2015 Andreas started a postdoc in the group of Professor Steven V. Ley at the University of Cambridge, UK. After his postdoc, he worked in chemical and analytical development at Novartis in Basel for 1.5 years. Andreas joined SynphaBase in 2019 as a project manager.
DR. WOLFGANG HEYDENREUTER PROJECT LEADER
Wolfgang studied chemistry at the Technical University (TUM) in Munich. After an internship with Prof. Barry Trost at Stanford University, he joined the group of Prof. Stephan Sieber at TUM to do a doctorate in organic synthesis and chemical biology. He then moved to ETH Zurich as a postdoc to deal with tumor targeting and organocatalysis under the direction of Prof. Helma Wennemers.
DR. MANUEL SCHERER PROJECT LEADER
After completing his Master of Science in chemistry at the University of Basel, Manuel completed his doctorate in total synthesis with Prof. Karl Gademann at the universities of Basel and Zurich. With a grant from the Swiss National Science Foundation, he then worked on a postdoc research project in the group of Prof. Steve Withers at the University of British Columbia in Vancouver with a focus on carbohydrate chemistry.